Skip to main content
Fig. 1 | Pilot and Feasibility Studies

Fig. 1

From: Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study

Fig. 1

Multidimensional scaling DS plot illustrating similarities between patients based on their immune response to MIS416. The maximum level of immune factors detected in patient plasma following MIS416 treatment (Table 5) was used to compare each patient’s overall immune response to MIS416 with the group. Clusters of patients with similar immune responses are outlined as a group. The patient responder status based on clinical improvement as determined in this study (Table 4) is indicated

Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784